Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

6.27
Delayed Data
As of Feb 17
 +0.19 / +3.12%
Today’s Change
4.41
Today|||52-Week Range
9.83
+26.16%
Year-to-Date
No recent news for Amicus Therapeutics Inc.

Today’s Trading

Previous close6.08
Today’s open6.06
Day’s range5.95 - 6.28
Volume2,305,239
Average volume (3 months)3,184,292
Market cap$892.4M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-29.03%
Earnings growth (this year)-16.64%
Earnings growth (next 5 years)+34.97%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
CLCDCoLucid Pharmaceutic...-0.10-0.22%
ZIOPZIOPHARM Oncology In...+0.05+0.73%
CORTCorcept Therapeutics...-0.05-0.66%
AMPHAmphastar Pharmaceut...+0.40+2.22%
Data as of 4:14pm ET, 02/17/2017

Financials

Last reporting dateFebruary 20, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$132.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts


Search for Jobs